The global pediatric perfusion market comprises devices and disposables that are used to oxygenate and circulate blood externally during cardiac surgery in infants and young children. These products are required for procedures such as cardiovascular surgeries, organ transplant surgeries, and extracorporeal membrane oxygenation (ECMO). Pediatric perfusion enables safer and more efficient surgeries in pediatric patients with complex congenital heart diseases and lessen surgical risks. Congenital heart diseases affect nearly 1% of live births each year and are one of the leading causes of infant mortality. With the increasing prevalence of such diseases, demand for pediatric perfusion devices is rising significantly.
The Global Pediatric Perfusion Market is estimated to be valued at US$ 574.7 MN in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the Global Pediatric Perfusion Market Size are Medtronic, GE Healthcare, LivaNova, Inc., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc. These players are focusing on new product launches, expansions, acquisitions, and partnerships to strengthen their market position.
Some of the key opportunities in the global pediatric perfusion market include growing medical tourism in developing countries for pediatric cardiac surgeries and rising investments by key players and governments in developing advanced extracorporeal life support technologies.
Moreover, with significant burden of congenital heart diseases worldwide, leading players are expanding their operations globally, especially in emerging markets in Asia Pacific, Latin America, and Middle East & Africa. This is expected to boost the overall pediatric perfusion market growth during the forecast period.
Market Drivers
- Rising prevalence of complex congenital heart diseases globally is a key factor driving the demand for pediatric perfusion devices and disposables. According to WHO, nearly 1% of total births reported congenital heart anomalies each year globally.
- Increasing support from governments and medical insurance providers for pediatric cardiac surgeries is encouraging the adoption of pediatric perfusion products.
Market Restraints
- High cost of pediatric perfusion devices and procedures limits their access in low and middle-income countries.
- Shortage of trained perfusionists poses operational challenges, especially in emerging markets.
Segment Analysis
The global pediatric perfusion market is dominated by the neonatal and pediatric cardiothoracic surgery segment. Children undergoing complex congenital heart disease correction surgeries form a major part of demand in this segment. Pediatric cardiac surgeries often require cardiopulmonary bypass that involves oxygenation and circulation support of the blood during surgery, driving the need for perfusion services and products. The risk of complications is also relatively higher in complex pediatric cardiac procedures compared to others, increasing utilization of perfusion monitoring and management.
Global Analysis
North America holds the largest share in the global pediatric perfusion market, supported by availability of advanced healthcare facilities and skilled professionals. The region is estimated to witness the highest growth driven by growing prevalence of congenital heart diseases and increasing pediatric cardiac surgeries. Asia Pacific region is expected to showcase significant growth on account of rising healthcare investments and expansion of tertiary care centers with pediatric cardiac surgery capabilities in countries like India, China and Japan. Moreover, growing medical tourism for cardiac treatments in Asian nations contributes to regional market growth.
Get more insights on This Topic- Global Pediatric Perfusion Market
